Raymond James & Associates Mimedx Group, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 14,242 shares of MDXG stock, worth $131,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,242

Previous 15,259 6.66%

Holding current value

$131,026

Previous $105,000 20.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$5.65 - $7.76 $5,746 - $7,891	-1,017 Reduced 6.66%	14,242 $84,000
Q2 2024 Jul 19, 2024	BUY	$6.16 - $8.08 $18,510 - $24,280	3,005 Added 24.52%	15,259 $105,000
Q1 2024 Apr 22, 2024	SELL	$7.61 - $8.63 $5,448 - $6,179	-716 Reduced 5.52%	12,254 $94,000
Q4 2023 Jan 16, 2024	BUY	$5.7 - $9.14 $73,929 - $118,545	12,970 New	12,970 $113,000
Q2 2023 Jul 25, 2023	SELL	$3.14 - $6.61 $12,874 - $27,101	-4,100 Reduced 7.4%	51,314 $339,000
Q4 2022 Feb 08, 2023	BUY	$2.63 - $3.45 $10,783 - $14,145	4,100 Added 7.99%	55,414 $154,000
Q3 2022 Oct 25, 2022	SELL	$2.71 - $4.22 $1,626 - $2,532	-600 Reduced 1.16%	51,314 $147,000
Q2 2022 Aug 12, 2022	BUY	$3.17 - $5.0 $133 - $210	42 Added 0.08%	51,914 $180,000
Q1 2022 May 11, 2022	SELL	$4.27 - $6.27 $22,784 - $33,456	-5,336 Reduced 9.33%	51,872 $244,000
Q4 2021 Feb 08, 2022	BUY	$5.7 - $8.48 $3,876 - $5,766	680 Added 1.2%	57,208 $346,000
Q3 2021 Nov 02, 2021	SELL	$5.52 - $15.83 $206,420 - $591,962	-37,395 Reduced 39.81%	56,528 $343,000
Q2 2021 Aug 11, 2021	SELL	$9.02 - $12.72 $481,758 - $679,375	-53,410 Reduced 36.25%	93,923 $1.18 Million
Q1 2021 May 14, 2021	BUY	$8.48 - $11.28 $626,697 - $833,625	73,903 Added 100.64%	147,333 $1.52 Million
Q4 2020 Feb 12, 2021	BUY	$5.32 - $10.17 $390,647 - $746,783	73,430 New	73,430 $667,000
Q4 2018 Feb 11, 2019	SELL	$1.15 - $6.45 $185,275 - $1.04 Million	-161,109 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.22 - $6.33 $14,168 - $27,852	-4,400 Reduced 2.66%	161,109 $996,000
Q2 2018 Aug 14, 2018	BUY	$5.39 - $8.96 $21,511 - $35,759	3,991 Added 2.47%	165,509 $1.06 Million
Q1 2018 May 14, 2018	SELL	$6.69 - $17.96 $115,629 - $310,420	-17,284 Reduced 9.67%	161,518 $1.13 Million
Q4 2017 Feb 14, 2018	SELL	$10.87 - $13.9 $369,210 - $472,127	-33,966 Reduced 15.96%	178,802 $2.26 Million
Q3 2017 Nov 13, 2017	BUY	$11.86 - $17.34 $425,299 - $621,812	35,860 Added 20.27%	212,768 $2.53 Million
Q2 2017 Aug 14, 2017	BUY	N/A	176,908	176,908 $2.65 Million

Others Institutions Holding MDXG

# of Institutions

209

Shares Held

98.2M

Call Options Held

Put Options Held

65.3K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.05B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Mimedx Group, Inc. Transaction History